Ingenza was named Innovator of the Year for the development of its inABLE platform to accelerate the commercialisation of new biological entities and processes. This Made in Scotland Award acknowledges the launch or creation of a product or process with substantial commercial potential.
Ingenza was recognised for its proprietary combinatorial genetic platform, inABLE®, which helps to improve the speed and predictability of bioengineering processes. This technology has opened up new commercial opportunities for Ingenza, expanding its customer base to incorporate a wide range of sectors, including bio-based chemicals, agrochemicals and biopharma.
Further success was enjoyed as Ingenza was also a finalist in the Life Sciences Company of the Year category, and the company’s recognition by the Made in Scotland awards is a testament to its integrated approach – combining molecular biology, fermentation and process chemistry capabilities to help realise new commercial opportunities in bio-based manufacturing. This unique blend of expertise enables the company to accelerate bioprocess development, driving the delivery of greener processes for application across the chemical, polymer, energy and pharma sectors.
The runner-up for Life Sciences Company of the Year, Ingenza , was named Innovator of the Year for the development of its inABLE platform to accelerate the commercialisation of new biological entities and processes.
A spin-out from the University of Edinburgh, Ingenza has grown from a team of four scientists to employing 44 people at its facilities at Roslin BioCentre.
“It's been a roller-coaster ride as a small company from Ingenza in 2002 as a very small company, and I just want to thank all the Ingenza staff and everyone who believed in the company from the beginning and thought we could change the world and make it a better place and bring medicines and innovative products wherever we can, so thank you very much.”
Ian Fotheringham, Managing Director of Ingenza